These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. GSTP1 CpG island hypermethylation for DNA-based detection of occult tumor cells in surgical margins after radical prostatectomy. Jentzmik F; Krause H; Reichelt U; Schrader AJ; Schrader M; Baumunk D; Cash H; Miller K; Schostak M World J Urol; 2012 Aug; 30(4):541-6. PubMed ID: 21947551 [TBL] [Abstract][Full Text] [Related]
7. Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort. Jhun MA; Geybels MS; Wright JL; Kolb S; April C; Bibikova M; Ostrander EA; Fan JB; Feng Z; Stanford JL Oncotarget; 2017 Jun; 8(26):43035-43047. PubMed ID: 28496006 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive disease. Kamoun A; Cancel-Tassin G; Fromont G; Elarouci N; Armenoult L; Ayadi M; Irani J; Leroy X; Villers A; Fournier G; Doucet L; Boyault S; Brureau L; Multigner L; Diedhiou A; Roupret M; Compérat E; Blanchet P; de Reyniès A; Cussenot O Ann Oncol; 2018 Aug; 29(8):1814-1821. PubMed ID: 29945238 [TBL] [Abstract][Full Text] [Related]
9. Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men. Ross AE; Johnson MH; Yousefi K; Davicioni E; Netto GJ; Marchionni L; Fedor HL; Glavaris S; Choeurng V; Buerki C; Erho N; Lam LL; Humphreys EB; Faraj S; Bezerra SM; Han M; Partin AW; Trock BJ; Schaeffer EM Eur Urol; 2016 Jan; 69(1):157-65. PubMed ID: 26058959 [TBL] [Abstract][Full Text] [Related]
10. Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression. Liu W; Hou J; Petkewicz J; Na R; Wang CH; Sun J; Gallagher J; Bogachkov YY; Swenson L; Regner M; Resurreccion WK; Isaacs WB; Brendler CB; Crawford S; Zheng SL; Helfand BT; Xu J Prostate; 2020 Oct; 80(14):1253-1262. PubMed ID: 32803894 [TBL] [Abstract][Full Text] [Related]
11. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy. Klein EA; Yousefi K; Haddad Z; Choeurng V; Buerki C; Stephenson AJ; Li J; Kattan MW; Magi-Galluzzi C; Davicioni E Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945 [TBL] [Abstract][Full Text] [Related]
12. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. Prensner JR; Zhao S; Erho N; Schipper M; Iyer MK; Dhanasekaran SM; Magi-Galluzzi C; Mehra R; Sahu A; Siddiqui J; Davicioni E; Den RB; Dicker AP; Karnes RJ; Wei JT; Klein EA; Jenkins RB; Chinnaiyan AM; Feng FY Lancet Oncol; 2014 Dec; 15(13):1469-1480. PubMed ID: 25456366 [TBL] [Abstract][Full Text] [Related]
13. Barry KH; Mohanty K; Erickson PA; Wang D; Shi J; Rose G; Cellini A; Clark K; Ambulos N; Yin J; Yan L; Poulin M; Meyer A; Zhang Y; Bentzen SM; Burke A; Hussain A; Berndt SI Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374332 [TBL] [Abstract][Full Text] [Related]
14. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Klein EA; Cooperberg MR; Magi-Galluzzi C; Simko JP; Falzarano SM; Maddala T; Chan JM; Li J; Cowan JE; Tsiatis AC; Cherbavaz DB; Pelham RJ; Tenggara-Hunter I; Baehner FL; Knezevic D; Febbo PG; Shak S; Kattan MW; Lee M; Carroll PR Eur Urol; 2014 Sep; 66(3):550-60. PubMed ID: 24836057 [TBL] [Abstract][Full Text] [Related]
15. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer. Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003 [TBL] [Abstract][Full Text] [Related]
16. Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model. Tollefson MK; Karnes RJ; Kwon ED; Lohse CM; Rangel LJ; Mynderse LA; Cheville JC; Sebo TJ Mayo Clin Proc; 2014 Mar; 89(3):308-18. PubMed ID: 24486077 [TBL] [Abstract][Full Text] [Related]
17. Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy. Khan MA; Walsh PC; Miller MC; Bales WD; Epstein JI; Mangold LA; Partin AW; Veltri RW Cancer; 2003 Dec; 98(12):2583-91. PubMed ID: 14669277 [TBL] [Abstract][Full Text] [Related]
18. Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy. Guimaraes MS; Quintal MM; Meirelles LR; Magna LA; Ferreira U; Billis A Int Braz J Urol; 2008; 34(1):23-9. PubMed ID: 18341718 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Pathological and Oncologic Outcomes of Favorable Risk Gleason Score 3 + 4 and Low Risk Gleason Score 6 Prostate Cancer: Considerations for Active Surveillance. Gearman DJ; Morlacco A; Cheville JC; Rangel LJ; Karnes RJ J Urol; 2018 May; 199(5):1188-1195. PubMed ID: 29225057 [TBL] [Abstract][Full Text] [Related]
20. Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy. Viers BR; Sukov WR; Gettman MT; Rangel LJ; Bergstralh EJ; Frank I; Tollefson MK; Thompson RH; Boorjian SA; Karnes RJ Eur Urol; 2014 Dec; 66(6):1116-24. PubMed ID: 25052213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]